|
Dr. Gammon has more than 20 years of experience in biomedical research and 10 years experience in the biotechnology industry, and brings to Receptor BioLogix broad knowledge of drug development from basic research to the clinic. He was previously vice president of clinical development at CancerVax Corp., where he had overall responsibility for conducting two Phase 3 clinical trials that enrolled over 1600 melanoma patients in 13 countries. Before that, he served as senior director, clinical trials at John Wayne Cancer Institute, where he established a Phase 3 clinical trial program and supervised numerous Phase 2 oncology trials. Previously, he was program head of immunology drug discovery at Xenova PLC, and earlier was an assistant research immunologist at UCLA. He received his M.B., B.S. (M.D. equivalent) in 1979 at the University College Hospital Medical School in London, and in 1982 he became a Member of the Royal College of Physicians. | 